1. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002; 46:1019–27.
Article
2. Cervera R, Asherson RA, Acevedo ML, Gómez-Puerta JA, Espinosa G, De La Red G, et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis. 2004; 63:1312–7.
Article
3. Wells PS, Anderson DR, Rodger M, Stiell I, Dreyer JF, Barnes D, et al. Excluding pulmonary embolism at the bed-side without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med. 2001; 135:98–107.
Article
4. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4:295–306.
Article
5. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002; 346:752–63.
Article
6. Misita CP, Moll S. Antiphospholipid antibodies. Circulation. 2005; 112:e39–44.
Article
7. Dalekos GN, Zachou K, Liaskos C. The antiphospholipid syndrome and infection. Curr Rheumatol Rep. 2001; 3:277–85.
Article
8. Asherson RA, Cervera R. Antiphospholipid antibodies and infections. Ann Rheum Dis. 2003; 62:388–93.
Article
9. Ioannou Y, Giles I, Lambrianides A, Richardson C, Pearl LH, Latchman DS, et al. A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli. BMC Biotechnol. 2006; 6:8.
Article
10. Cicconi V, Carloni E, Franceschi F, Nocente R, Silveri NG, Manna R, et al. Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication. Am J Med. 2001; 111:163–4.
Article
11. Blank M, George J, Fishman P, Levy Y, Toder V, Savion S, et al. Ciprofloxacin immunomodulation of experimental anti-phospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. Arthritis Rheum. 1998; 41:224–32.
Article
12. Kang WS, Min JW, Park SJ, Lee MK, Park CS, Chung JH. A case of septic azygos vein embolism caused by staphylococcus aureus bacteremia. Tuberc Respir Dis (Seoul). 2012; 72:328–31.
13. Okur A, Intepe YS, Serin HI, Yı ldı rım U, Mavili E. Recurrent pulmonary embolism in an asthmatic patient who had inter-rupted inferior vena cava with azygous continuation. Turk Kardiyol Dern Ars. 2014; 42:277–80.
Article
14. Hellfritzsch MB. General anatomy and musculoskeletal system. Acta Radiol. 2015; 56:NP24.
Article
15. Vallianou N, Lazarou V, Tzangarakis J, Barounis R, Sioula E. Pulmonary embolism as the first manifestation of multiple myeloma. Case Rep Med. 2013; 2013; 236913.
Article